AHNS Series

Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma

The Education Committee of the American Head and Neck Society (AHNS)

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

This article is a continuation of the “Do You Know Your Guidelines” series, initiated by the Education committee of the American Head and Neck Society. Treatment guidelines for advanced head and neck squamous cell carcinoma are reviewed here, including the critical roles of radiotherapy, chemotherapy, and the recent application of immunotherapy agents. We will be limiting this discussion to include cancers of the oral cavity, oropharynx, hypopharynx, and larynx. It should be noted that much of the article pertains to human papillomavirus (HPV)-negative oropharyngeal cancer where applicable, as HPV-positive oropharyngeal squamous cell carcinoma carries a different natural history, different prognosis, and now different staging criteria. Additionally, the article will not include information on nasopharyngeal or sinus cancers, as these latter topics are covered in separate “Do you know your guidelines?” installments and these diagnoses carry somewhat different approaches to diagnosis and management that diverge from the focus of this article.

Original languageEnglish (US)
Pages (from-to)676-686
Number of pages11
JournalHead and Neck
Volume40
Issue number4
DOIs
StatePublished - Apr 1 2018

Fingerprint

Guidelines
Oropharyngeal Neoplasms
Hypopharynx
Oropharynx
Mouth Neoplasms
Larynx
Natural History
Immunotherapy
Mouth
Squamous Cell Carcinoma
Radiotherapy
Therapeutics
Education
Drug Therapy
Carcinoma, squamous cell of head and neck
Neoplasms

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology

Cite this

The Education Committee of the American Head and Neck Society (AHNS). / AHNS Series : Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma. In: Head and Neck. 2018 ; Vol. 40, No. 4. pp. 676-686.
@article{3ec09e66b0c84aacb77d988dc43029e7,
title = "AHNS Series: Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma",
abstract = "This article is a continuation of the “Do You Know Your Guidelines” series, initiated by the Education committee of the American Head and Neck Society. Treatment guidelines for advanced head and neck squamous cell carcinoma are reviewed here, including the critical roles of radiotherapy, chemotherapy, and the recent application of immunotherapy agents. We will be limiting this discussion to include cancers of the oral cavity, oropharynx, hypopharynx, and larynx. It should be noted that much of the article pertains to human papillomavirus (HPV)-negative oropharyngeal cancer where applicable, as HPV-positive oropharyngeal squamous cell carcinoma carries a different natural history, different prognosis, and now different staging criteria. Additionally, the article will not include information on nasopharyngeal or sinus cancers, as these latter topics are covered in separate “Do you know your guidelines?” installments and these diagnoses carry somewhat different approaches to diagnosis and management that diverge from the focus of this article.",
author = "{The Education Committee of the American Head and Neck Society (AHNS)} and Fulcher, {Cory D.} and Missak Haigentz and Missak Haigentz",
year = "2018",
month = "4",
day = "1",
doi = "10.1002/hed.25025",
language = "English (US)",
volume = "40",
pages = "676--686",
journal = "Head and Neck",
issn = "1043-3074",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

AHNS Series : Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma. / The Education Committee of the American Head and Neck Society (AHNS).

In: Head and Neck, Vol. 40, No. 4, 01.04.2018, p. 676-686.

Research output: Contribution to journalArticle

TY - JOUR

T1 - AHNS Series

T2 - Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma

AU - The Education Committee of the American Head and Neck Society (AHNS)

AU - Fulcher, Cory D.

AU - Haigentz, Missak

AU - Haigentz, Missak

PY - 2018/4/1

Y1 - 2018/4/1

N2 - This article is a continuation of the “Do You Know Your Guidelines” series, initiated by the Education committee of the American Head and Neck Society. Treatment guidelines for advanced head and neck squamous cell carcinoma are reviewed here, including the critical roles of radiotherapy, chemotherapy, and the recent application of immunotherapy agents. We will be limiting this discussion to include cancers of the oral cavity, oropharynx, hypopharynx, and larynx. It should be noted that much of the article pertains to human papillomavirus (HPV)-negative oropharyngeal cancer where applicable, as HPV-positive oropharyngeal squamous cell carcinoma carries a different natural history, different prognosis, and now different staging criteria. Additionally, the article will not include information on nasopharyngeal or sinus cancers, as these latter topics are covered in separate “Do you know your guidelines?” installments and these diagnoses carry somewhat different approaches to diagnosis and management that diverge from the focus of this article.

AB - This article is a continuation of the “Do You Know Your Guidelines” series, initiated by the Education committee of the American Head and Neck Society. Treatment guidelines for advanced head and neck squamous cell carcinoma are reviewed here, including the critical roles of radiotherapy, chemotherapy, and the recent application of immunotherapy agents. We will be limiting this discussion to include cancers of the oral cavity, oropharynx, hypopharynx, and larynx. It should be noted that much of the article pertains to human papillomavirus (HPV)-negative oropharyngeal cancer where applicable, as HPV-positive oropharyngeal squamous cell carcinoma carries a different natural history, different prognosis, and now different staging criteria. Additionally, the article will not include information on nasopharyngeal or sinus cancers, as these latter topics are covered in separate “Do you know your guidelines?” installments and these diagnoses carry somewhat different approaches to diagnosis and management that diverge from the focus of this article.

UR - http://www.scopus.com/inward/record.url?scp=85035072599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035072599&partnerID=8YFLogxK

U2 - 10.1002/hed.25025

DO - 10.1002/hed.25025

M3 - Article

VL - 40

SP - 676

EP - 686

JO - Head and Neck

JF - Head and Neck

SN - 1043-3074

IS - 4

ER -